Variation in thyroid status in patients with graves' orbitopathy

Acta Endocrinologica

Volumn 5, Issue 2, 2009, Pages 191-198

  Cozma, I ^a   Cozma, L S ^a   Boyce, R L ^a   Ludgate, M E ^a   Lazarus, J H ^a   Lane, C M ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Graves' disease; Hypothyroidism; Orbitopathy; Smoker

Indexed keywords

EID: 70549112923     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2009.191     Document Type: Article

References (32)

1. Solomon DH, Chopra IJ, Chopra U, Smith FJ. Identification of subgroups of euthyroid Graves' ophthalmopathy. N Engl J Med 1977;296(4):181-186.
2. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman, C.A. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121(3):284-290.
3. Tani J, Yoshida K, Fukazawa H, Kiso Y, Sayama N, Mori K, Aizawa Y, Hori H. Nakasato N, Abe K. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports. Endocr J. 1998;45(1):117-121.
4. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol 2003; 148(5):491-495.
5. Khoo DH, Ho SC, Seah LL, Fong KS, Tai ES, Chee SP, Eng PH, Aw SE, Fok AC The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999;9(12):1175-1180.
6. Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 1990;150(5):1098-1101.
7. Kim JM, LaBree L, Levin L, Feldon SE. The relation of Graves' ophthalmopathy to circulating thyroid hormone status. Br J Ophthalmol 2004;88(1):72-74.
8. Gleeson H, Kelly W, Toft A, Dickinson J, Kendall-Taylor P, Fleck B, Perros P. Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy. Thyroid 1999;9(11):1115-1118.
9. Zimmerman L. Exophthalmos following operation for relief of hypothyroidism. Am J Med Sci 1929;178:92-99.
10. Barbosa J, Wong E, Doe RP. Ophthalmopathy of Graves' disease. Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs. Arch Intern Med 1972;130(1):111-113.
11. Huysmans AK, Hermus RM, Edelbroek MA, Tjabbes T, Oostdijk, Ross HA, Corstens FH, Kloppenborg PW. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid. 1997;7(4):535-539.
12. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 2005;90(9):5321-5323.
13. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1997;47(1):9-14.
14. Lazarus JH, Marino M. Orbit-Thyroid Relarionship. in Graves' Orbitopathy A Multidisciplinary Approach. Editors: W.M. Wiersinga and G.J. Kahaly 2007,27-33 Karger, Basel
15. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321(20):1349-1352.
16. Gwinup G, Elias AN, Ascher MS. Effect on exophthalmos of various methods of treatment of Graves' disease. Jama. 1982;247(15):2135-2138.
17. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998;129(8):632-635.
18. Marcocci C, Bruno-Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 1999; 51(4):503-508.
19. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M, Hamberger B. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine-a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab 1996;81(8):2986-2993.
20. Frilling A, Goretzki PE, Grussendorf M, Erbsloh M, Roher HD. The influence of surgery on endocrine ophthalmopathy. World J Surg 1990;14(3):442-445; discussion 445-446.
21. Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh). 1989;120(4):473-478.
22. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. Clinical features of Graves' ophthalmopathy in an incidence cohort. 1996 Mar;121(3):284-290.
23. Perros P, Crombie AL, Matthews JN, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 1993;38(4):367-372.
24. Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol. 1993;111(2):197-201.
25. Neigel JM, Rootman J, Belkin RI, Nugent RA, Drance SM, Beattie CW, Spinelli JA. Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology. 1988;95(11):1515-1521.
26. Gorman CA. Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983;58(8):515-519.
27. Wiersinga WM, Smit T, van der Gaag R, Koornneef L. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 1988;11(8):615-619.
28. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves' ophthalmopathy and smoking. Lancet 1990;335(8700):1261-1263.
29. Vestergaard P. Smoking and thyroid disorders-a meta-analysis. Eur J Endocrinol 2002;146(2):153-1561.
30. Krassas GE, Wiersinga W. Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 2006 Jun;154(6):777-780.
31. Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin. Endoc Metab 2006;91(12):4873-4880.
32. Burch HB, Wartofsky L Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747-793